Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignanciesJosé María Sánchez‐Pina, María Calbacho, Mario Rodríguez et al.|European Journal Of Haematology|2020Cited by 96
Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid‐19 patientsMario Rodríguez, Joaquín Martínez‐López, Nerea Castro Quismondo et al.|International Journal of Laboratory Hematology|2021Cited by 30
Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global networkA. Sanz, Joaquín Martínez‐López, Rosa Ayala et al.|Blood Cancer Journal|2022Cited by 24
Clinical Course and Risk Factors for Mortality from COVID-19 in Patients with Hematological MalignanciesJosé María Sánchez‐Pina, María Calbacho, Mario Rodríguez et al.|SSRN Electronic Journal|2020Cited by 1
Abstract 4820: Anti-CD72 nanobody-based CAR-T affinity maturation leads to improved in vitro efficacy versus low antigen density lymphoma models, but limited benefit in vivoAdila Izgutdina, Arun P. Wiita, Tasfia Rashid et al.|Cancer Research|2025Cited by 1